New York Mesothelioma attorneys discuss the two 'asbestos exposure in the workplace' cases recently joined by the Supreme Court.
(PRWEB) October 16, 2007 -- Two New York Mesothelioma/asbestos legal claims involving asbestos exposure in the workplace, filed by Levy Philips & Konigsberg, LLP, have been joined for trial based upon a recent legal court decision. On September 24, 2007, Justice Marcy S. Friedman, Supreme Court, New York County, located in downtown New York City, announced a ruling that joins the two mesothelioma cases, both being legal claims for mesothelioma/asbestos exposure in the workplace, for a single trial to begin on November 5, 2007.
The Court's Order joins the cases of Joel and Sharon Rosenberg v. Alpha Wire Company, et. al, Index No. 106697/06 and Joseph and Dolores Casale, Index No. 104299/06. Mr. Rosenberg resided in Jackson, New Jersey when he developed pleural mesothelioma due to workplace asbestos exposure; he died from this asbestos cancer at the age of 64. Mr. Casale, who is living with pleural mesothelioma at the age of 65, resides in Lantana, Florida. Mesothelioma attorneys from Levy Phillips & Konigsberg LLP filed these legal claims regarding asbestos/mesothelioma in the New York City Asbestos Litigation, as each man suffered significant exposure to asbestos while working in New York City.
Mr. Rosenberg, a life-long electrician with the International Brotherhood of Electrical Workers ("IBEW"), Local 3, started in the trade while still a teenager in 1960. Mr. Rosenberg's workplace asbestos exposure occurred while working in the electrician trade in work sites in New York. Mesothelioma due to workplace asbestos exposure developed in Mr. Rosenberg from a variety of worksites including the Arthur Kill Powerhouse in Staten Island, the World Trade Center, Kennedy Airport and Rockefeller Center. The asbestos/mesothelioma legal claim seeks money damages for Mr. Rosenberg's pain and suffering resulting from his mesothelioma. continues. Electricians, such as Mr. Rosenberg, sustained asbestos exposure in the workplace from a variety of sources including the cutting and splicing of wire and cable that was insulated with asbestos, as well as the drilling of asbestos-containing electrical control panels.
Mr. Casale was a career steam fitter (also known as pipe fitter). At the time, steamfitters were unknowingly endangered with asbestos exposure in their workplace due to asbestos being used in boilers and other equipment. While still a teenager Mr. Casale worked at shipyards, including the Brooklyn Navy Yard, as a member of the Local 638 Union. Mr. Casale continued in the same union and worked in the steam fitter trade at job sites in New York City throughout the 1960s and 1970s. Mr. Casale later moved to Florida but due to his asbestos exposure in the workplace while still in New York, mesothelioma was diagnosed and immediately linked to his previous occupation. Mr. Casale's occupation caused his workplace asbestos exposure from equipment, including pumps, valves, and boilers, as well as from gaskets and insulation.
Justice Friedman joined these two mesothelioma/asbestos legal claims into a single trial based upon New York Civil Practice Law and Rule ("CPLR") Section 602 which permits cases to be joined for trial to "avoid unnecessary costs or delay." The defendants in the lawsuit argued that the cases should be tried separately because Mr. Rosenberg and Mr. Casale worked in different trades and their claimed workplace asbestos exposure occurred at different job sites. But the New York mesothelioma attorneys from Levy Philips & Konigsberg, LLP, convinced the Court that these cases should be tried together to save costs and insure that each family received their day in court as soon as possible.
The trial of these New York City mesothelioma/asbestos legal claims is expected to last approximately six weeks, and will feature the testimony of Mr. Casale, Mr. Rosenberg, their wives and children, along with a host of expert witnesses, with expertise in areas such as occupational medicine, history and public health.
The trial will take place in Justice Friedman's courtroom located at 80 Centre Street in Manhattan.
For more information about this mesothelioma trial, or for more information about mesothelioma in New York and New Jersey, asbestos exposure in the workplace or your rights regarding asbestos awareness at your jobsite you may call the mesothelioma attorneys at Levy, Phillips & Konigsberg LLP at 800-MESO-LAW or 212-605-6200 or complete the email form on this page. You will also find informative medical and asbestos/mesothelioma legal claim information for New York and New Jersey at www.nynjmesothelioma.com.
Press Contact: Jay Berkowitz
Company Name: Levy Philips & Konigsberg, LLP
Phone: 561-620-9121
Website: http://www.nynjmesothelioma.com/new-york-mesothelioma-claims.php
Asbestos discovered after flooding of Redlands City Hall; LegalView offers wealth of asbestos and Mesothelioma guidance.
Denver, CO (PRWEB) October 25, 2007 -- When City Hall in Redlands City, California was flooded last week with gray water backed up from the city's sewage system, the initial concern was e coli bacteria. Another danger, however, was quickly identified by city workers; hazardous levels of asbestos. An asbestos remediation company has been brought in and workers have been relocated as cleanup efforts are delayed due to this dangerous discovery.
Asbestos was widely used in building insulation in the first half of the 20th century. We now know that exposure to asbestos can lead to mesothelioma, a crippling type of lung cancer that attacks the lining of the lung. Unlike most lung cancers, mesothelioma is not caused by smoking, according to the National Cancer Institute; the Institute reports that 80 percent of mesothelioma patients had known asbestos exposure earlier in life. Mesothelioma can kill quickly; on average, doctors give patients six months to a year to live after their diagnosis. With this in mind, LegalView.com continues to provide factual information, news and links to more information for mesothelioma patients and their families through its mesothelioma information internet portal.
LegalView.com strives to bring its readers complete, up-to-date information on legal issues that affect ordinary Americans. In addition to the mesothelioma resources, LegalView.com offers comprehensive sites with information concerning brain injury litigation, auto accident lawsuits, or construction accident attorneys. These are in addition to general resources LegalView.com maintains on possible unsafe drugs, medical malpractice cases, and defective consumer products and foods. All of these sites, and others at LegalView.com, combine easy-to-understand information facts with the latest news, government information, jury verdicts and settlements, as well as links to more information specific to each legal issue. And for those who are ready to seek out a mesothelioma attorney or other type of experienced lawyer can find one in their areas using LegalView.com's free attorney search service.
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's respected sponsoring law firms and to get in touch with LegalView.com attorneys, visit LegalView.com at http://www.legalview.com/.
Press Contact: Alan Haburchak
Company Name: LegalView.com
Phone: 720 771-3246
Website: www.legalview.com
Exodon announces a new clinical research trial to combat break through cancer pain. The focus of the campaign is to study the efficacy of a new nasal spray.
Mount Arlington, NJ (PRWEB) October 20, 2007 -- Exodon LLC, a leading international clinical research company, announces the start of a new clinical trial for break through cancer pain (BTCP). The clinical trial will be is being conducted by Archimedes Development, Ltd.
Exodon is currently recruiting patients suffering from break through cancer related pain (BTCP). The focus of this clinical trial is to study the efficacy of a new nasal formation of an on-the-market opioid for BTCP. Oral opioid analgesics in pill or injection form take time to work and these medications remain active well after the break through pain has stopped. Because of these issues, this trial is researching a nasal spray application of an opioid medication. The opioid in the form of a nasal spray offers the benefits of a more rapid onset with decreased side-effect profile and can be used with the patient's current opioid medications for BTCP.
Break through pain is pain that is not controlled by the regular doses of pain medicines and is often a severe flare of pain that can occur even if patients are taking medicine for other types of pain.
"Since break through pain is not predictable and medication is only taken at the onset of pain, it is important for the drugs to take effect as soon as possible," says Gerald Tramontano, Ph.D., Director of Clinical Research of Exodon. "That is why a nasal spray has an advantage over other types of medicinal applications. We have a history of working with many leading hospitals and physicians and believe this trial will be of interest nationwide."
Trial participants pay no diagnostic or treatment costs related to the BTCP clinical trial.
Visit http://www.exodon.com for criteria for inclusion in this clinical trial and for more information about all of Exodon's current and upcoming clinical trials.
About Exodon
Exodon is an international clinical research organization which specializes in patient and investigator recruitment services. We have a robust network of pre-consented patients and researchers ready and available for entry into clinical trial research studies.
We reduce the patient/site recruitment time and increase patient retention through our proprietary system, the VALIDATE System®. Most of our sites participate in our VALIDATE System network resulting in a database that enables real-time access to real de-identified medical records. This enables Exodon to search for pre-qualified patients meeting the study's inclusion or exclusion criteria. The company's website can be found at http://www.exodon.com.
Press Contact: Liz Garger
Company Name: Exodon LLC
Phone: 9175724820
Website: www.exodon.com
Marler Clark files E. coli Lawsuit Against Cargill
October 15, 2007 - SEATTLE--(BUSINESS WIRE)--An E. coli lawsuit was filed today in Minnesota against Cargill Meat Solutions Corporation, the meat company whose frozen ground beef products were identified as the source of an E. coli O157:H7 outbreak in September and October. The lawsuit was filed in Dakota County District Court on behalf of Dakota County residents Eric and Jennifer Gustafson and their two children, Callie and Carson, who both suffered E. coli infections after eating Cargill ground beef patties at a barbecue in September. Callie's E. coli infection led to hemolytic uremic syndrome, and she was hospitalized for seven days.
The Gustafson children's cases were two of three E. coli cases that triggered an investigation by the Minnesota Department of Health and Minnesota Department of Agriculture which eventually led to Cargill's recall of 845,000 pounds of frozen ground beef patties for E. coli contamination on October 6, 2007. The Cargill products were sold at retail establishments, including Sam's Club, and to restaurants and other institutions throughout the United States. Since the investigation began in Minnesota, E. coli illnesses tied to Cargill ground beef products have been identified in Minnesota (5), Wisconsin (5), North Carolina (2) and Tennessee (3). Many of the E. coli cases involve children or young adults with HUS. According to news reports, children in Minnesota and Tennessee still remain hospitalized in critical condition.
"This is not the first time that Cargill or one of its many subsidiaries has had E. coli-related problems that led to illness," said William Marler of Marler Clark, the Gustafsons' attorney, who pointed out that he has represented victims of prior E. coli outbreaks traced to Cargill products. "In 2000, Cargill was implicated as the seller of E. coli-contaminated meat during the Milwaukee Sizzler E. coli outbreak that sickened 60 and killed one young girl. In July 2001, Cargill recalled 200,000 pounds of ground beef after being linked to an illness in Georgia. And again in 2002, Cargill sickened 57 in Wisconsin and Minnesota and recalled over 500,000 pounds of contaminated ground beef."
Since spring of 2007, nearly 30 million pounds of ground beef has been recalled in the United States. Marler added, "It seems like the wheels are coming off the beef industry. With millions of pounds of meat pulled from shelves and hundreds sickened, there must be a through investigation of an industry clearly out of control."
BACKGROUND: William Marler has been involved in E. coli cases since the Jack in the Box outbreak of 1993, when he won a settlement of $15.6 million for nine-year-old Brianne Kiner. His firm, Marler Clark, has prosecuted dozens of E. coli cases in Minnesota, including those related to the 2007 ground beef E. coli outbreak traced to PM Beef Holdings and Lunds Food Holdings; the 2006 E. coli outbreak stemming from consumption of E. coli-contaminated ground beef produced by Nebraska Beef and sold at Supervalu, then served at a church supper in Longville, Minnesota; the 2006 E. coli outbreak traced to the consumption of Dole brand baby spinach; a 2006 E. coli outbreak at Taco John's restaurants that was ultimately traced back to E. coli-contaminated lettuce; an E. coli outbreak in 2001 that was traced to a China Buffet restaurant; and an E. coli outbreak in 2000 linked to ground beef produced by AFG and sold by Supervalu and Cub Foods.
Marler comments on food safety and E. coli outbreaks on his blog, www.marlerblog.com. More about Marler Clark can be found at www.marlerclark.com.
Contacts
Marler Clark
Suzanne Schreck, 206-346-1879
sschreck@marlerclark.com
RxHub Supports New Hampshire ePrescribing Initiative
RxHub National Patient Health Information Network provides critical decision support data for medication therapy management and electronic prescribing at the point of care
October 10, 2007 - ST. PAUL, Minn.--(BUSINESS WIRE)--RxHub® today announced support for New Hampshire's new initiative to provide health care clinicians with the ability to ePrescribe statewide, which was unveiled at a press conference today by Governor John Lynch and Dr. Philip Boulter of the New Hampshire Citizens Health Initiative.
"Moving to electronic prescriptions is an important step forward in improving health care efficiency, controlling costs, reducing medical errors and increasing patient safety." Gov. Lynch said. "New Hampshire is making real progress in ensuring all of our health care providers have the capability of prescribing medication electronically."
The NH Citizens Health Initiative is a health care collaborative effort that seeks to create a system of care that promotes improved health status and outcomes, assured outcomes, and care that is accessible affordable, effective and safe. "Probably the most significant development over the last year is the technology infrastructure, or ePrescribing hub if you will, that is pretty much in place thanks to partners including RxHub." Stated Dr. Boulter.
Tom Groom, Senior Vice President of Business Development for RxHub, attended the program's kickoff meeting and complimented the progress made on the state's ePrescribing initiative. "We applaud the leadership provided by Governor Lynch and the effectiveness of the Citizens Health Initiative. RxHub is proud to provide authorized physicians in New Hampshire with critical real-time patient prescription data that can indicate clinically appropriate and cost effective prescription options at the point of care," stated Groom.
Last year the Institute of Medicine admonished all physicians to begin using ePrescribing in order to prevent the 1.5 million medication errors that occur each year. ePrescribing is perhaps the most effective and underutilized tool that American healthcare offers to improve patient safety, reduce costs and eliminate wasteful paperwork. By connecting authorized physicians electronically to their patient's health records, it empowers physicians to know three things vital to patient safety and drug affordability:
1. ePrescribing informs physicians if a drug being prescribed would interact harmfully with other drugs - including those prescribed by other doctors - that a patient is already taking;
2. ePrescribing shows physicians and patients the full range of clinically safe drug and pharmacy choices available so that, together, they can make the most effective and affordable choice on a case-by-case basis;
3. ePrescribing eliminates illegible handwritten prescriptions that pharmacists and others can so easily misinterpret, often with unfortunate results.
"No doctor can possibly know the potential side effects with all of these combinations, and patients do not always tell all their doctors all the medications they take," Gov. Lynch said. "With e-prescribing, physicians and their office staffs will benefit from access to online information about potential hazardous drug-to-drug interactions and drug allergy reactions, making it easier to prescribe the right drug, with the proper dosage, the first time."
RxHub is a universal ePrescribing solution for the nation. The RxHub National Health Information NetworkT connects authorized physicians and pharmacists to critical prescription information for consenting patients at the point of care. This information enables clinicians to effectively manage the patients' use of medications and counsel patients on safe and affordable choices before prescriptions are electronically transmitted to retail and mail order pharmacies. RxHub is contracted to provide vital patient-specific prescription information for more than 200 million Americans - representing over 90% of the commercially covered lives in the United States.
About NH Citizens Health Initiative
The NH Citizens Health Initiative is a health care collaborative effort that seeks to create a system of care that promotes health, where quality is assured, and care is accessible affordable, effective and safe. The initiative brings together a broad cross section of citizen representatives, joined by businesses, medical providers, and community agencies in an ongoing, goal-oriented effort to implement a comprehensive health care plan for our state.
About RxHub LLC
RxHub® (www.rxhub.net) manages the RxHub National Patient Health Information NetworkT which electronically routes up-to-date patient-specific medication history and prescription benefit information to caregivers at every point of care. Our end-to-end solution enables physicians to prescribe the most clinically appropriate and cost effective prescription and send it electronically to the patient's pharmacy of choice. Operating as a cost recovery business model, RxHub partners with stakeholders in the prescribing industry to improve patient safety, increase workflow efficiency and reduce the overall cost of health care delivery. For more information on RxHub Certified Partners, please visit: http://www.rxhub.net/partners.html.
Contacts
RxHub, LLC
Chris Van Horrick, 651-855-3078
Chris.vanhorrick@rxhub.net
